Zobrazeno 1 - 10
of 11
pro vyhledávání: '"MESH: Interferon Alfa-2a"'
Differential Receptor Subunit Affinities of Type I Interferons Govern Differential Signal Activation
Publikováno v:
Journal of Molecular Biology
Journal of Molecular Biology, Elsevier, 2007, 366 (2), pp.525-39. ⟨10.1016/j.jmb.2006.11.053⟩
Journal of Molecular Biology, Elsevier, 2007, 366 (2), pp.525-39. ⟨10.1016/j.jmb.2006.11.053⟩
Type I interferons (IFNs) elicit antiviral, antiproliferative and immunmodulatory responses by binding to a shared cell surface receptor comprising the transmembrane proteins ifnar1 and ifnar2. Activation of differential response patterns by IFNs has
Autor:
Hézode , Christophe, Forestier , Nicole, Dusheiko , Geoffrey, Ferenci , Peter, Pol , Stanislas, Goeser , Tobias, Bronowicki , Jean-Pierre, Bourlière , Marc, Gharakhanian , Shahin, Bengtsson , Leif, McNair , Lindsay, George , Shelley, Kieffer , Tara, Kwong , Ann, Kauffman , Robert, Alam , John, Pawlotsky , Jean-Michel, Zeuzem , Stefan
Publikováno v:
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2009, 360 (18), pp.1839-50. ⟨10.1056/NEJMoa0807650⟩
New England Journal of Medicine, Massachusetts Medical Society, 2009, 360 (18), pp.1839-50. 〈10.1056/NEJMoa0807650〉
New England Journal of Medicine, Massachusetts Medical Society, 2009, 360 (18), pp.1839-50. ⟨10.1056/NEJMoa0807650⟩
New England Journal of Medicine, Massachusetts Medical Society, 2009, 360 (18), pp.1839-50. 〈10.1056/NEJMoa0807650〉
International audience; BACKGROUND: In patients with chronic infection with hepatitis C virus (HCV) genotype 1, treatment with peginterferon alfa and ribavirin for 48 weeks results in rates of sustained virologic response of 40 to 50%. Telaprevir is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0f5757e84789258ce37e0c6da27dcd82
https://www.hal.inserm.fr/inserm-00385235/file/1839.pdf
https://www.hal.inserm.fr/inserm-00385235/file/1839.pdf
Autor:
Thevenot, Thierry, Boruchowicz, Arnaud, Henrion, Jean, Nalet, Bernard, Moindrot, Henri, Renseigné, Non
Publikováno v:
Digestive Diseases and Sciences
Digestive Diseases and Sciences, Springer Verlag, 2007, 52 (5), pp.1310-2. ⟨10.1007/s10620-006-9360-5⟩
Digestive Diseases and Sciences, Springer Verlag, 2007, 52 (5), pp.1310-2. ⟨10.1007/s10620-006-9360-5⟩
International audience
Publikováno v:
Statistics in Medicine
Statistics in Medicine, Wiley-Blackwell, 2011, 30 (10), pp.1045-56. ⟨10.1002/sim.4191⟩
Statistics in Medicine, 2011, 30 (10), pp.1045-56. ⟨10.1002/sim.4191⟩
Statistics in Medicine, Wiley-Blackwell, 2011, 30 (10), pp.1045-56. ⟨10.1002/sim.4191⟩
Statistics in Medicine, 2011, 30 (10), pp.1045-56. ⟨10.1002/sim.4191⟩
International audience; Mathematical modeling of hepatitis C viral (HCV) kinetics is widely used for understanding viral pathogenesis and predicting treatment outcome. The standard model is based on a system of five non-linear ordinary differential e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd17533ffc8d4276448cace8c70dc3ca
https://www.hal.inserm.fr/inserm-00615142/document
https://www.hal.inserm.fr/inserm-00615142/document
Autor:
Frébet, Elise, Abraham, Julie, Geneviève, Franck, Lepelley, Pascale, Daliphard, Sylvie, Bardet, Valérie, Amsellem, Sophie, Guy, Julien, Mullier, Francois, Durrieu, Francoise, Venon, Marie-Dominique, Leleu, Xavier, Jaccard, Arnaud, Faucher, Jean-Luc, Béné, Marie C, Feuillard, Jean, Renseigné, Non
Publikováno v:
Cytometry Part B Clinical Cytometry
Cytometry Part B Clinical Cytometry, 2010, 363 (26), epub ahead of print. ⟨10.1002/cyto.b.20581⟩
Cytometry Part B: Clinical Cytometry
Cytometry Part B: Clinical Cytometry, Wiley, 2011, 80 (3), pp.176-85. ⟨10.1002/cyto.b.20581⟩
Cytometry Part B Clinical Cytometry, 2010, 363 (26), epub ahead of print. ⟨10.1002/cyto.b.20581⟩
Cytometry Part B: Clinical Cytometry
Cytometry Part B: Clinical Cytometry, Wiley, 2011, 80 (3), pp.176-85. ⟨10.1002/cyto.b.20581⟩
International audience; BACKGROUND:: Flow cytometry is the sole available technique for quantification of tumor plasma-cells in plasma-cell disorders, but so far, no consensus technique has been proposed. Here, we report on a standardized, simple, ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7361e9d3a693ce2d228c45674af1f66d
https://hal.archives-ouvertes.fr/hal-00559641
https://hal.archives-ouvertes.fr/hal-00559641
Autor:
Olivier Cassar, Antoine Petit, Isabelle Moulonguet, Jacqueline Rivet, Antoine Gessain, Daniel Wallach, Félix Agbalika, Arnaud Duval
Publikováno v:
Acta Dermato-Venereologica Supplementum
Acta Dermato-Venereologica Supplementum, Society for Publication of Acta Dermato-Venereologica, 2010, 90 (3), pp.287-90. ⟨10.2340/00015555-0846⟩
Acta Dermato-Venereologica Supplementum, 2010, 90 (3), pp.287-90. ⟨10.2340/00015555-0846⟩
Acta Dermato-Venereologica Supplementum, Society for Publication of Acta Dermato-Venereologica, 2010, 90 (3), pp.287-90. ⟨10.2340/00015555-0846⟩
Acta Dermato-Venereologica Supplementum, 2010, 90 (3), pp.287-90. ⟨10.2340/00015555-0846⟩
International audience; Prurigo nodularis is a pruritic dermatosis of unknown origin. Human T-cell lymphotropic virus type 1 (HTLV-1) causes adult T-cell leukaemia/lymphoma. HTLV-1 is not considered to be a cause of prurigo nodularis. A 52-year-old b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61b02eb1936e72e33b42090fd546927e
https://hal-pasteur.archives-ouvertes.fr/pasteur-00531222
https://hal-pasteur.archives-ouvertes.fr/pasteur-00531222
Autor:
Hézode, Christophe, Forestier, Nicole, Dusheiko, Geoffrey, Ferenci, Peter, Pol, Stanislas, Goeser, Tobias, Bronowicki, Jean-Pierre, Bourlière, Marc, Gharakhanian, Shahin, Bengtsson, Leif, Mcnair, Lindsay, George, Shelley, Kieffer, Tara, Kwong, Ann, Kauffman, Robert, Alam, John, Pawlotsky, Jean-Michel, Zeuzem, Stefan
Publikováno v:
New England Journal of Medicine
New England Journal of Medicine, 2009, 360 (18), pp.1839-50. ⟨10.1056/NEJMoa0807650⟩
New England Journal of Medicine, 2009, 360 (18), pp.1839-50. ⟨10.1056/NEJMoa0807650⟩
International audience; BACKGROUND: In patients with chronic infection with hepatitis C virus (HCV) genotype 1, treatment with peginterferon alfa and ribavirin for 48 weeks results in rates of sustained virologic response of 40 to 50%. Telaprevir is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1398::0f5757e84789258ce37e0c6da27dcd82
https://doi.org/10.1056/NEJMoa0807650
https://doi.org/10.1056/NEJMoa0807650
Autor:
Eric Nerrienet, Michèle Tagni Sartre, Christophe Pasquier, Isabelle Timba, Patrice Tchendjou, Dominique Rousset, Richard Njouom
Publikováno v:
Journal of Medical Virology
Journal of Medical Virology, Wiley-Blackwell, 2008, 80 (12), pp.2079-85. ⟨10.1002/jmv.21319⟩
Journal of Medical Virology, Wiley-Blackwell, 2008, 80 (12), pp.2079-85. ⟨10.1002/jmv.21319⟩
International audience; Data were examined from a day-to-day clinical practice in Yaounde, Cameroon to evaluate the efficacy and safety of peginterferon alfa-2a and ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C. Ninety ad
Autor:
Eric, Snoeck, Stephanos J, Hadziyannis, Claudio, Puoti, Mark G, Swain, Thomas, Berg, Patrick, Marcellin, Jean-Pierre, Zarski, Karin, Jorga, Stefan, Zeuzem
Publikováno v:
Liver International
Liver International, Wiley-Blackwell, 2008, 28 (1), pp.61-71. ⟨10.1111/j.1478-3231.2007.01603.x⟩
Liver International, Wiley-Blackwell, 2008, 28 (1), pp.61-71. ⟨10.1111/j.1478-3231.2007.01603.x⟩
International audience; BACKGROUND: Currently, the approved dosage of ribavirin has not been studied in patients with 'normal' alanine aminotransferase (ALT) levels. METHODS: Modelling and simulations were performed using generalised additive models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a006f400992a02d0d43ea3275158e11f
https://www.hal.inserm.fr/inserm-00324956
https://www.hal.inserm.fr/inserm-00324956
Autor:
Jean-Pierre Zarski, Tania Dufeu-Duchesne, Vincent Leroy, M.A. Thelu, Patrice N. Marche, Muhammad Ramzan
Publikováno v:
Journal of Medical Virology
Journal of Medical Virology, 2007, 79 (3), pp.242-53. ⟨10.1002/jmv.20792⟩
Journal of Medical Virology, Wiley-Blackwell, 2007, 79 (3), pp.242-53. ⟨10.1002/jmv.20792⟩
Journal of Medical Virology, 2007, 79 (3), pp.242-53. ⟨10.1002/jmv.20792⟩
Journal of Medical Virology, Wiley-Blackwell, 2007, 79 (3), pp.242-53. ⟨10.1002/jmv.20792⟩
In the proof, we asked to correct the name of one Author, and the adddess; this was acknowledged by the Editor, but was omitted in the final published version!; International audience; At the early stage of treatment, IFN alpha-2a induces inhibition